Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$34.8M |
| 2 |
Kinder Morgan
KMI
|
+$27.8M |
| 3 |
EOG Resources
EOG
|
+$27.5M |
| 4 |
Medtronic
MDT
|
+$27.1M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$42.7M |
| 2 |
Apple
AAPL
|
+$36.5M |
| 3 |
Comcast
CMCSA
|
+$33.5M |
| 4 |
CVS Health
CVS
|
+$30.9M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$29.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.53% |
| 2 | Technology | 15.96% |
| 3 | Consumer Discretionary | 14.59% |
| 4 | Healthcare | 13.04% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Textron
TXT
$14.3B
| $883K | 0.02% |
+33,103
| New | +$1.34M |
|
577
Anika Therapeutics
ANIK
$291M
| $879K | 0.02% |
30,414
+11,036
| +57% | +$446K |
|
578
Fair Isaac
FICO
$25.3B
| $876K | 0.02% |
2,847
-9,376
| -77% | -$3.45M |
|
579
Ventas
VTR
$47.7B
| $875K | 0.02% |
+32,634
| New | +$1.62M |
|
580
Choice Hotels
CHH
$4.93B
| $874K | 0.02% |
14,275
+1,583
| +12% | +$144K |
|
581
AppFolio
APPF
$7.95B
| $870K | 0.02% |
7,845
-6,388
| -45% | -$762K |
|
582
Huntsman Corp
HUN
$1.75B
| $869K | 0.02% |
60,243
-56,500
| -48% | -$1.1M |
|
583
Silgan Holdings
SLGN
$4.48B
| $864K | 0.02% |
+29,776
| New | +$896K |
|
584
Corcept Therapeutics
CORT
$13.2B
| $860K | 0.02% |
72,343
-5,791
| -7% | -$71.7K |
|
585
Alkermes
ALKS
$8.11B
| $858K | 0.02% |
+59,514
| New | +$1.06M |
|
|
ANSS
586
DELISTED
Ansys
ANSS
| $849K | 0.02% |
3,653
-174
| -5% | -$44.9K |
|
|
CTRA
587
DELISTED
Coterra Energy
CTRA
| $845K | 0.02% |
49,179
+12,057
| +32% | +$191K |
|
588
Exelixis
EXEL
$13.4B
| $844K | 0.02% |
49,007
-56,894
| -54% | -$1.04M |
|
589
Range Resources
RRC
$9.59B
| $842K | 0.02% |
369,172
-1,072,442
| -74% | -$3.42M |
|
|
TIF
590
DELISTED
Tiffany & Co.
TIF
| $841K | 0.02% |
+6,493
| New | +$854K |
|
591
Arcosa
ACA
$7.12B
| $827K | 0.02% |
+20,811
| New | +$880K |
|
592
Canadian National Railway
CNI
$78.5B
| $827K | 0.02% |
10,655
+4,005
| +60% | +$349K |
|
|
DBD
593
DELISTED
Diebold Nixdorf Incorporated
DBD
| $826K | 0.02% |
234,560
-188,385
| -45% | -$1.6M |
|
|
PENG
594
Penguin Solutions Inc
PENG
$2.7B
| $825K | 0.02% |
67,892
+6,048
| +10% | +$88.5K |
|
595
Texas Roadhouse
TXRH
$13.4B
| $824K | 0.02% |
+19,963
| New | +$1.1M |
|
596
Booz Allen Hamilton
BAH
$9.27B
| $823K | 0.02% |
11,988
-27,191
| -69% | -$2M |
|
|
MRC
597
DELISTED
MRC Global
MRC
| $823K | 0.02% |
193,197
-23,881
| -11% | -$224K |
|
598
Murphy USA
MUSA
$10.5B
| $822K | 0.02% |
9,744
-9,318
| -49% | -$967K |
|
599
EverQuote
EVER
$889M
| $821K | 0.02% |
31,269
+2,416
| +8% | +$85.1K |
|
600
Sabre
SABR
$848M
| $820K | 0.02% |
138,250
-20,281
| -13% | -$339K |
|
Similar funds
Joel Greenblatt's Q1 2020 Portfolio in Review
As of Q1 2020, Joel Greenblatt held 1,293 positions worth $3.6B, down 34% from $5.45B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Joel Greenblatt withdrew a net $266M in Q1 2020, closing 238 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $28.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Joel Greenblatt opened a new position in CONCHO RESOURCES INC. worth $16.6M.
- Joel Greenblatt's largest Q1 2020 buy was CONCHO RESOURCES INC.: 388,298 shares worth $16.6M.
- Joel Greenblatt added most to TJX Companies in Q1 2020, an estimated $34.8M increase.
- Joel Greenblatt's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $42.7M.
- Joel Greenblatt fully exited Johnson Controls International in Q1 2020, selling an estimated $28.1M.
- Joel Greenblatt's ten largest holdings make up 9.7% of its $3.6B portfolio in Q1 2020.
- Joel Greenblatt opened 206 new positions and closed 238 in Q1 2020.
- Joel Greenblatt's portfolio value fell 34% quarter-over-quarter to $3.6B.
Based on Gotham Asset Management's 13F filing for Q1 2020, filed 15 May 2020.